Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Lisa M DunkleKaren L KotloffCynthia L GayGermán ÁñezJeffrey M AdelglassAlejandro Q Barrat HernándezWayne L HarperDaniel M DuncansonMonica A McArthurDiana F FlorescuR Scott McClellandVeronica Garcia-FragosoRobert A RiesenbergDavid B MusanteDavid L FriedBeth E SafirsteinMark McKenzieRobert J JeanfreauJeffrey K KingsleyJeffrey A HendersonDakotah C LaneGuillermo M Ruíz-PalaciosLawrence CoreyKathleen M NeuzilRobert W CoombsAlex L GreningerJulia HutterJulie A AkeKatherine SmithWayne WooIksung ChoGregory M GlennFilip Dubovskynull nullPublished in: The New England journal of medicine (2021)
NVX-CoV2373 was safe and effective for the prevention of Covid-19. Most breakthrough cases were caused by contemporary variant strains. (Funded by Novavax and others; PREVENT-19 ClinicalTrials.gov number, NCT04611802.).